Pharma Tilleul SRL
2.4 FTEPharma Tilleul reported total assets of 912,565 € at the end of the 2025 financial year (annual accounts filed with the NBB on 27 Aug 2026), with 2.4 full-time equivalents.
The score of Pharma Tilleul shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Accounts of the company itself (not consolidated).
Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Pharma Tilleul's annual accounts
| 2025 | |
|---|---|
| Net result | 52,374 € |
| Equity | 52,374 € |
| Cash | 39,136 € |
| EBITDA | 122,429 € |
| Total assets | 912,565 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 27 Aug 2026
Pharma Tilleul's financial analysis
- Solvency5.7%sector median: 41.5%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Pharma Tilleul
Pharma Tilleul's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 1016.644.429
- VAT number
- BE1016644429
- Peppol
- Registered · 0208:1016644429 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 26 Nov 2024
- Registered office
- 6110 Montigny-le-Tilleul
- Size
- Micro · 2.4 FTE
- Latest accounts
- 2025 · filed on 27 Aug 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Pharma Tilleul (SRL) has been based in Montigny-le-Tilleul since 2024, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 52,374 € and equity of 52,374 €; its revenue is not published. With 2.4 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 5.7%, below the median of its sector (41.5%).
Companies similar to Pharma Tilleul
Companies in the same business, of comparable size and area, outside its group.
- Pharmacie DU Beau Site Retail sale of pharmaceutical products Charleroi · balance sheet 918,444 €
- Apotheek Claudy Meysen Retail sale of pharmaceutical products Leopoldsburg · balance sheet 912,361 €
- Pharmanema Retail sale of pharmaceutical products Leuven · balance sheet 910,021 €
- Pharmuny Retail sale of pharmaceutical products Ellezelles · balance sheet 909,631 €
- Propharma Retail sale of pharmaceutical products Ottignies-Louvain-la-Neuve · balance sheet 915,541 €
- Novil'Pharma Retail sale of pharmaceutical products Fernelmont · balance sheet 907,966 €
- Holsbeek Deurne Retail sale of pharmaceutical products Antwerp · balance sheet 917,585 €
- COX Retail sale of pharmaceutical products Hasselt · balance sheet 917,941 €
Frequently asked questions about Pharma Tilleul
What is the revenue of Pharma Tilleul?
Pharma Tilleul files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Pharma Tilleul?
In Belgium, the VAT number is the company number prefixed with BE: BE1016644429 for Pharma Tilleul, if the company is VAT-registered. Its company number (CBE) is 1016.644.429.
Where is the registered office of Pharma Tilleul?
According to the CBE register, the registered office of Pharma Tilleul is in 6110 Montigny-le-Tilleul.
What is the equity of Pharma Tilleul?
At the close of the 2025 financial year, the equity of Pharma Tilleul amounts to 52,374 €, a solvency of 5.7% of total assets.
How many people work at Pharma Tilleul?
2.4 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Pharma Tilleul?
The register lists 2 active mandates at Pharma Tilleul. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Pharma Tilleul
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →